The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-Ethyl-2-methyl-7-((5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl)methyl)-5-oxo-5H-thiazolo[3,2-a]pyrimidine-3-carboxamide ID: ALA3799438
Chembl Id: CHEMBL3799438
PubChem CID: 122438374
Max Phase: Preclinical
Molecular Formula: C16H16F3N5O2S
Molecular Weight: 399.40
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CCNC(=O)c1c(C)sc2nc(Cn3nc(C(F)(F)F)cc3C)cc(=O)n12
Standard InChI: InChI=1S/C16H16F3N5O2S/c1-4-20-14(26)13-9(3)27-15-21-10(6-12(25)24(13)15)7-23-8(2)5-11(22-23)16(17,18)19/h5-6H,4,7H2,1-3H3,(H,20,26)
Standard InChI Key: SVFAUFCIEMCAAH-UHFFFAOYSA-N
Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 399.40Molecular Weight (Monoisotopic): 399.0977AlogP: 2.39#Rotatable Bonds: 4Polar Surface Area: 81.29Molecular Species: NEUTRALHBA: 7HBD: 1#RO5 Violations: 0HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski): 0CX Acidic pKa: CX Basic pKa: 0.88CX LogP: 2.11CX LogD: 2.11Aromatic Rings: 3Heavy Atoms: 27QED Weighted: 0.73Np Likeness Score: -2.33
References 1. Volgraf M, Sellers BD, Jiang Y, Wu G, Ly CQ, Villemure E, Pastor RM, Yuen PW, Lu A, Luo X, Liu M, Zhang S, Sun L, Fu Y, Lupardus PJ, Wallweber HJ, Liederer BM, Deshmukh G, Plise E, Tay S, Reynen P, Herrington J, Gustafson A, Liu Y, Dirksen A, Dietz MG, Liu Y, Wang TM, Hanson JE, Hackos D, Scearce-Levie K, Schwarz JB.. (2016) Discovery of GluN2A-Selective NMDA Receptor Positive Allosteric Modulators (PAMs): Tuning Deactivation Kinetics via Structure-Based Design., 59 (6): [PMID:26919761 ] [10.1021/acs.jmedchem.5b02010 ]